UBS Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-99,157
| Closed | -$3.42M | – | 8000 |
|
|
2020
Q3 | $3.42M | Buy |
99,157
+14,483
| +17% | +$499K | ﹤0.01% | 1990 |
|
|
2020
Q2 | $1.42M | Buy |
84,674
+22,435
| +36% | +$375K | ﹤0.01% | 2547 |
|
|
2020
Q1 | $898K | Buy |
62,239
+29,175
| +88% | +$421K | ﹤0.01% | 2751 |
|
|
2019
Q4 | $1.11M | Sell |
33,064
-70,416
| -68% | -$2.36M | ﹤0.01% | 3249 |
|
|
2019
Q3 | $2.17M | Buy |
103,480
+67,449
| +187% | +$1.41M | ﹤0.01% | 2538 |
|
|
2019
Q2 | $750K | Buy |
36,031
+19,082
| +113% | +$397K | ﹤0.01% | 3238 |
|
|
2019
Q1 | $379K | Sell |
16,949
-67,894
| -80% | -$1.52M | ﹤0.01% | 3515 |
|
|
2018
Q4 | $2.03M | Buy |
84,843
+75,509
| +809% | +$1.81M | ﹤0.01% | 2428 |
|
|
2018
Q3 | $255K | Sell |
9,334
-230
| -2% | -$6.28K | ﹤0.01% | 4068 |
|
|
2018
Q2 | $257K | Sell |
9,564
-118,670
| -93% | -$3.19M | ﹤0.01% | 3947 |
|
|
2018
Q1 | $4.08M | Buy |
128,234
+114,846
| +858% | +$3.66M | ﹤0.01% | 2012 |
|
|
2017
Q4 | $506K | Sell |
13,388
-4,605
| -26% | -$174K | ﹤0.01% | 3457 |
|
|
2017
Q3 | $446K | Buy |
17,993
+10,449
| +139% | +$259K | ﹤0.01% | 3523 |
|
|
2017
Q2 | $155K | Buy |
7,544
+6,604
| +703% | +$136K | ﹤0.01% | 4039 |
|
|
2017
Q1 | $20K | Sell |
940
-2,637
| -74% | -$56.1K | ﹤0.01% | 5235 |
|
|
2016
Q4 | $73K | Buy |
3,577
+3,477
| +3,477% | +$71K | ﹤0.01% | 4638 |
|
|
2016
Q3 | $2K | Sell |
100
-80
| -44% | -$1.6K | ﹤0.01% | 6498 |
|
|
2016
Q2 | $2K | Sell |
180
-2,061
| -92% | -$22.9K | ﹤0.01% | 6542 |
|
|
2016
Q1 | $30K | Buy |
2,241
+1,641
| +274% | +$22K | ﹤0.01% | 5087 |
|
|
2015
Q4 | $11K | Hold |
600
| – | – | ﹤0.01% | 5968 |
|
|
2015
Q3 | $15K | Buy |
+600
| New | +$15K | ﹤0.01% | 5686 |
|